7 Analysts Have This To Say About Abbott Laboratories
Portfolio Pulse from Benzinga Insights
Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter show a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $125.0, with a high of $140.00 and a low of $119.00. Recent ratings adjustments include both raises and lowers in price targets.
July 02, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts' ratings for Abbott Laboratories (NYSE:ABT) show mixed sentiments with an average 12-month price target of $125.0. Recent adjustments include both raises and lowers in price targets.
The mixed analyst ratings and recent adjustments in price targets indicate a neutral short-term impact on Abbott Laboratories' stock price. The average price target has slightly decreased, reflecting cautious optimism among analysts.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100